Hematology
News
Consider mental health and social factors in management of sickle cell disease
Screen sickle cell disease patients for depression and mental health issues, especially those reporting higher levels of pain.
News
“Terrific progress”: Adding blinatumomab for infant leukemia
Immunotherapy plus chemotherapy improves outcomes and may soon become first-line treatment for a rare pediatric blood cancer.
News
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
Opinion
Hydroxyurea underused in youth with sickle cell anemia
An expert says providers must tell families that their children need to take it every day, no matter the severity of disease.
News
Surviving CLL: Higher risk of other cancer DXs
A 30-year Dutch population study highlights the medical challenges facing patients with CLL, who are now living longer.
News
Despite limits, COVID vaccines protect CLL patients
A small German study found that, in patients with CLL, COVID-19 shots don’t boost B cells but they do strengthen T cells.
News
FDA approves pirtobrutinib for r/r mantle cell lymphoma
Pirtobrutinib for relapsed or refractory mantle cell lymphoma has been approved by the Food and Drug Administration.
News
Adding venetoclax improves ibrutinib outcomes in CLL
A small study yields sanguine news about a combination treatment, as hematologists await phase 3 results.
News
High cost and demand for old cancer drug sparks crisis
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
News
FDA approves first gene therapy for hemophilia B
The gene therapy will cost $3.5 million, making it the most expensive treatment to date.
